Incannex Healthcare Inc (IXHL)
2.85
-0.14
(-4.68%)
USD |
NASDAQ |
May 31, 16:00
2.83
-0.02
(-0.70%)
After-Hours: 20:00
Incannex Healthcare Enterprise Value: 35.93M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 35.93M |
| May 30, 2024 | 38.16M |
| May 29, 2024 | 37.36M |
| May 28, 2024 | 36.09M |
| May 24, 2024 | 34.82M |
| May 23, 2024 | 33.55M |
| May 22, 2024 | 33.39M |
| May 21, 2024 | 33.23M |
| May 20, 2024 | 31.25M |
| May 17, 2024 | 30.38M |
| May 16, 2024 | 34.82M |
| May 15, 2024 | 36.73M |
| May 14, 2024 | 39.27M |
| May 13, 2024 | 32.28M |
| May 10, 2024 | 31.01M |
| May 09, 2024 | 31.17M |
| May 08, 2024 | 29.58M |
| May 07, 2024 | 28.63M |
| May 06, 2024 | 27.36M |
| May 03, 2024 | 28.63M |
| May 02, 2024 | 31.17M |
| May 01, 2024 | 33.08M |
| April 30, 2024 | 36.57M |
| April 29, 2024 | 30.70M |
| April 26, 2024 | 25.93M |
| Date | Value |
|---|---|
| April 25, 2024 | 27.20M |
| April 24, 2024 | 26.57M |
| April 23, 2024 | 26.89M |
| April 22, 2024 | 28.00M |
| April 19, 2024 | 28.47M |
| April 18, 2024 | 28.47M |
| April 17, 2024 | 29.11M |
| April 16, 2024 | 29.27M |
| April 15, 2024 | 32.76M |
| April 12, 2024 | 38.00M |
| April 11, 2024 | 40.22M |
| April 10, 2024 | 40.22M |
| April 09, 2024 | 39.11M |
| April 08, 2024 | 40.22M |
| April 05, 2024 | 42.28M |
| April 04, 2024 | 45.93M |
| April 03, 2024 | 43.55M |
| April 02, 2024 | 44.19M |
| April 01, 2024 | 46.73M |
| March 28, 2024 | 42.43M |
| March 27, 2024 | 36.24M |
| March 26, 2024 | 35.92M |
| March 25, 2024 | 35.45M |
| March 22, 2024 | 29.26M |
| March 21, 2024 | 28.62M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-9.069M
Minimum
Oct 24 2023
414.65M
Maximum
Mar 15 2022
32.95M
Average
28.63M
Median
May 03 2024
Enterprise Value Benchmarks
| Propanc Biopharma Inc | 1.221M |
| NovaBay Pharmaceuticals Inc | 4.387M |
| Palatin Technologies Inc | 19.03M |
| iBio Inc | 28.91M |
| Theriva Biologics Inc | -10.98M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.031M |
| Total Expenses (Quarterly) | 6.095M |
| EPS Diluted (Quarterly) | -0.38 |
| Earnings Yield | 36.82% |